Catinazzo Thomas - Insider Non-Derivative Transactions at Relay Therapeutics, Inc. (RLAY) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 29, 2024, Catinazzo Thomas's relationship to Relay Therapeutics, Inc. (RLAY) is Officer (Chief Financial Officer), and currently has 328,728 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RLAY insiders.

Data Source: SEC.
Catinazzo Thomas - Insider Non-Derivative Transactions of RLAY Common Stock
Catinazzo Thomas - Insider Non-Derivative Transactions at RLAY
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 30, 2024 Sell -- (Common Stock) 9078 8.51 319650
Jul 30, 2024 Sell -- (Common Stock) 1702 8.85 328728
Jun 28, 2024 Sell -- (Common Stock) 9078 6.24 330430
Jun 28, 2024 Sell -- (Common Stock) 295 6.26 339508
Apr 30, 2024 Sell -- (Common Stock) 1695 6.38 339803
Mar 28, 2024 Sell -- (Common Stock) 348 7.7 341498
Jan 30, 2024 Sell -- (Common Stock) 2005 9.64 341846
Jan 17, 2024 Acquisition -- (Common Stock) 200000 0 343851
Dec 28, 2023 Sell -- (Common Stock) 294 11.51 143851
Oct 31, 2023 Sell -- (Common Stock) 1697 6.03 144145
Sep 28, 2023 Sell -- (Common Stock) 294 8.38 145842
Jul 29, 2023 Sell -- (Common Stock) 1693 11.8 146136
Jun 28, 2023 Sell -- (Common Stock) 294 12.12 147829
Apr 29, 2023 Sell -- (Common Stock) 2012 11.16 148123
Apr 29, 2023 Sell -- (Common Stock) 863 11.16 149272
Mar 28, 2023 Sell -- (Common Stock) 347 15.36 150135
Jan 31, 2023 Sell -- (Common Stock) 864 21.56 150482
Jan 18, 2023 Acquisition -- (Common Stock) 101115 0 151346